BDNF is a novel marker of cognitive function in ageing women: The DR’s EXTRA Study

Brain-derived neurotrophic factor (BDNF) is one of the key molecules modulating brain plasticity. While low circulating levels of BDNF have been suggested to predispose to Alzheimer's disease, very little data are available on its association with cognitive function in general population. We evaluated the association between plasma BDNF levels and cognition in a representative population sample of ageing men and women. The subjects (n=1389) were participants of the Dose-Responses to Exercise Training (DR's EXTRA) Study and represent a random sample of Eastern Finnish people (684 men and 705 women), 57-79 years of age at baseline of the study. Plasma BDNF levels were measured by enzyme-linked immunosorbent assay (ELISA). Cognitive function was evaluated using the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsychological test battery. Women had a higher mean (+/-SEM) plasma BDNF level than men (1721+/-55vs. 1495+/-54pg/ml, P<0.001). In women, 1 SD decrease in BDNF increased the risk for a low score in Naming Test by 53% (95% CI 1.21-1.92, P<0.001), in Mini-Mental State Examination by 63% (95% CI 1.21-2.20, P=0.001), in Word List Memory by 56% (95% CI 1.08-2.26, P=0.019), in Word List Recall by 50% (95% CI 1.10-2.05, P=0.010), in Word List Saving by 49% (95% CI 1.12-1.99, P=0.007), and in Word List Recognition by 64% (95% CI 1.19-2.25, P=0.002). Data were adjusted for age, education, depression, impaired glucose metabolism, cardiovascular disease, antihypertensive medication, lipid lowering medication, use of sex hormones, smoking, alcohol consumption, storing time of plasma in the freezer and platelet count. BDNF was not associated with cognition in men. Present data suggest that plasma BDNF is a biomarker of impaired memory and general cognitive function in ageing women.

[1]  B. Lu,et al.  Neurotrophins and hippocampal synaptic transmission and plasticity , 1999, Journal of neuroscience research.

[2]  F. Sohrabji,et al.  Estrogen–BDNF interactions: Implications for neurodegenerative diseases , 2006, Frontiers in Neuroendocrinology.

[3]  J. Kleinman,et al.  BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan. , 2006, Gene expression patterns : GEP.

[4]  R G M Morris,et al.  Elements of a neurobiological theory of the hippocampus: the role of activity-dependent synaptic plasticity in memory. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[5]  F. Angelucci,et al.  NGF, BDNF, Leptin, and Mast Cells in Human Coronary Atherosclerosis and Metabolic Syndrome , 2001, Archives of physiology and biochemistry.

[6]  C. Bramham,et al.  BDNF function in adult synaptic plasticity: The synaptic consolidation hypothesis , 2005, Progress in Neurobiology.

[7]  P. Scheltens,et al.  Advances in the early detection of Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[8]  K. Kuroda,et al.  Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia. , 2006, European archives of psychiatry and clinical neuroscience.

[9]  L. Manni,et al.  Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. , 2005, International journal of cardiology.

[10]  J. Morrison,et al.  Estrogen, Menopause, and the Aging Brain: How Basic Neuroscience Can Inform Hormone Therapy in Women , 2006, The Journal of Neuroscience.

[11]  William A Banks,et al.  Transport of brain-derived neurotrophic factor across the blood–brain barrier , 1998, Neuropharmacology.

[12]  R. Holsinger,et al.  Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease. , 2000, Brain research. Molecular brain research.

[13]  J. Simpkins,et al.  The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. , 1995, Endocrinology.

[14]  C. Pike,et al.  Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. , 2001, Journal of neurochemistry.

[15]  K. Yaffe,et al.  Hormone replacement therapy for cognitive function in postmenopausal women ( Review ) , 2022 .

[16]  H. Scharfman,et al.  Similarities between actions of estrogen and BDNF in the hippocampus: coincidence or clue? , 2005, Trends in Neurosciences.

[17]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[18]  Hironori Ito,et al.  Age-related changes in BDNF protein levels in human serum: differences between autism cases and normal controls , 2007, International Journal of Developmental Neuroscience.

[19]  Meharvan Singh,et al.  Progesterone increases brain‐derived neuroptrophic factor expression and protects against glutamate toxicity in a mitogen‐activated protein kinase‐ and phosphoinositide‐3 kinase‐dependent manner in cerebral cortical explants , 2007, Journal of neuroscience research.

[20]  M. Schwald,et al.  Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets , 2002, Neuroscience Letters.

[21]  B. Michalski,et al.  Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease. , 2003, Brain research. Molecular brain research.

[22]  M. Tohyama,et al.  Growth factors prevent changes in Bcl-2 and Bax expression and neuronal apoptosis induced by nitric oxide , 1998, Cell Death and Differentiation.

[23]  Hilkka Soininen,et al.  Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study , 2006, The Lancet Neurology.

[24]  E. Castrén,et al.  Transgenic mice overexpressing the full-length neurotrophin receptor trkB exhibit increased activation of the trkB–PLCγ pathway, reduced anxiety, and facilitated learning , 2004, Molecular and Cellular Neuroscience.

[25]  J. Virchow,et al.  The impact of age, weight and gender on BDNF levels in human platelets and plasma , 2004, Neurobiology of Aging.

[26]  N. Burgess,et al.  The hippocampus and memory: insights from spatial processing , 2008, Nature Reviews Neuroscience.

[27]  P. Koudstaal,et al.  Silent brain infarcts: a systematic review , 2007, The Lancet Neurology.

[28]  L. White,et al.  Serum brain-derived neurotrophic factor response to aerobic exercise in multiple sclerosis , 2008, Journal of the Neurological Sciences.

[29]  M. Barrachina,et al.  Brain banks: benefits, limitations and cautions concerning the use of post-mortem brain tissue for molecular studies , 2008, Cell and Tissue Banking.

[30]  H. Eichenbaum.  Hippocampus Cognitive Processes and Neural Representations that Underlie Declarative Memory , 2004, Neuron.

[31]  K. Hashimoto,et al.  Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls , 2003, Neuroscience Letters.

[32]  K. Christian,et al.  BDNF: A key regulator for protein synthesis-dependent LTP and long-term memory? , 2008, Neurobiology of Learning and Memory.

[33]  L. Radloff.  The CES-D Scale , 1977 .

[34]  I. Izquierdo,et al.  BDNF–triggered events in the rat hippocampus are required for both short‐ and long‐term memory formation , 2002, Hippocampus.

[35]  J. Simpkins,et al.  Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione , 1998, Neuroscience.

[36]  M. Mattson.  Neuroprotective Signal Transduction: Relevance to Stroke , 1997, Neuroscience & Biobehavioral Reviews.

[37]  Stuart Maudsley,et al.  BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders , 2004, Trends in Neurosciences.

[38]  T. Strine,et al.  Dementia and Its Implications for Public Health , 2006, Preventing chronic disease.

[39]  S. Knecht,et al.  High impact running improves learning , 2007, Neurobiology of Learning and Memory.

[40]  A Hofman,et al.  Diabetes mellitus and the risk of dementia , 1999, Neurology.

[41]  R. Faull,et al.  Brain-derived neurotrophic factor is reduced in Alzheimer's disease. , 1997, Brain research. Molecular brain research.

[42]  J. Wuu,et al.  Precursor form of brain‐derived neurotrophic factor and mature brain‐derived neurotrophic factor are decreased in the pre‐clinical stages of Alzheimer's disease , 2005, Journal of neurochemistry.

[43]  J. Janowsky,et al.  Thinking with your gonads: testosterone and cognition , 2006, Trends in Cognitive Sciences.

[44]  M. Mattson,et al.  NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults , 1994, Brain Research.

[45]  Michael J. O'Donovan,et al.  Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. , 1995, The American journal of pathology.

[46]  J. Morris,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.

[47]  C. Bever,et al.  Brain derived neurotrophic factor treatment reduces inflammation and apoptosis in experimental allergic encephalomyelitis , 2008, Journal of the Neurological Sciences.

[48]  L. Zhang,et al.  Impairments in High-Frequency Transmission, Synaptic Vesicle Docking, and Synaptic Protein Distribution in the Hippocampus of BDNF Knockout Mice , 1999, The Journal of Neuroscience.

[49]  Ruoyan Chen,et al.  Brain-derived Neurotrophic Factor Is Stored in Human Platelets and Released by Agonist Stimulation , 2002, Thrombosis and Haemostasis.

[50]  N. Secher,et al.  Brain-derived neurotrophic factor (BDNF) and type 2 diabetes , 2007, Diabetologia.

[51]  R. Gibbs.  Treatment with estrogen and progesterone affects relative levels of brain-derived neurotrophic factor mRNA and protein in different regions of the adult rat brain , 1999, Brain Research.

[52]  A. Granholm,et al.  Progesterone counteracts estrogen-induced increases in neurotrophins in the aged female rat brain , 2004, Neuroreport.

[53]  W. Tyler,et al.  From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. , 2002, Learning & memory.

[54]  C. Frye,et al.  Estrogen-priming can enhance progesterone's anti-seizure effects in part by increasing hippocampal levels of allopregnanolone , 2005, Pharmacology Biochemistry and Behavior.

[55]  J. Aubry,et al.  Decreased serum brain-derived neurotrophic factor levels in major depressed patients , 2002, Psychiatry Research.

[56]  E. Schuman,et al.  Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus , 1995, Science.

[57]  R. Duman,et al.  Influence of estradiol, stress, and 5-HT2A agonist treatment on Brain-Derived Neurotrophic Factor expression in female rats , 2003, Biological Psychiatry.

[58]  I. Izquierdo,et al.  Persistence of Long-Term Memory Storage Requires a Late Protein Synthesis- and BDNF- Dependent Phase in the Hippocampus , 2007, Neuron.

[59]  James S. Williams,et al.  The effect of acute exercise on serum brain-derived neurotrophic factor levels and cognitive function. , 2007, Medicine and science in sports and exercise.

[60]  Hans Lassmann,et al.  Activated Human T Cells, B Cells, and Monocytes Produce Brain-derived Neurotrophic Factor In Vitro and in Inflammatory Brain Lesions: A Neuroprotective Role of Inflammation? , 1999, The Journal of experimental medicine.

[61]  Frank Z. Stanczyk,et al.  Progesterone and Estrogen Regulate Alzheimer-Like Neuropathology in Female 3xTg-AD Mice , 2007, The Journal of Neuroscience.

[62]  B. Sherwin.  Estrogen and cognitive aging in women , 2006, Neuroscience.

[63]  Eric J Topol,et al.  Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins , 2004, The Lancet.

[64]  M. Bartels,et al.  Stage-dependent BDNF serum concentrations in Alzheimer’s disease , 2006, Journal of Neural Transmission.

[65]  M. Murer,et al.  Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease , 2001, Progress in Neurobiology.

[66]  Olivier Beauchet,et al.  Testosterone and cognitive function: current clinical evidence of a relationship. , 2006, European journal of endocrinology.

[67]  I. Izquierdo,et al.  BDNF is essential to promote persistence of long-term memory storage , 2008, Proceedings of the National Academy of Sciences.